Doseology Sciences Inc (MOOD.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 20 | 66 | 140 | 93 |
| Accounts receivable | -39 | 15 | 68 | -57 | -28 |
| Other Working Capital | -8 | 33 | 137 | -284 | -917 |
| Other Operating Activity | -295 | -303 | -752 | -1,509 | -1,516 |
| Operating Cash Flow | $-342 | $-235 | $-481 | $-1,711 | $-2,368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | -6 | -146 |
| Net Acquisitions | N/A | N/A | N/A | 0 | 109 |
| Sale Of Investment | N/A | N/A | N/A | 0 | 35 |
| Purchase Sale Intangibles | N/A | N/A | 0 | -2 | -25 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-8 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -6 | -92 | -120 | -60 |
| Common Stock Issued | 731 | N/A | N/A | 0 | 3,845 |
| Common Stock Repurchased | N/A | N/A | N/A | 0 | -275 |
| Other Financing Activity | -19 | 0 | 0 | -20 | 2,277 |
| Financing Cash Flow | $712 | $-6 | $-92 | $-140 | $5,787 |
| Beginning Cash Position | 1,060 | 1,301 | 1,874 | 3,734 | 341 |
| End Cash Position | 1,430 | 1,060 | 1,301 | 1,874 | 3,734 |
| Net Cash Flow | $369 | $-241 | $-573 | $-1,859 | $3,393 |
| Free Cash Flow | |||||
| Operating Cash Flow | -342 | -235 | -481 | -1,711 | -2,368 |
| Capital Expenditure | N/A | N/A | N/A | -8 | -170 |
| Free Cash Flow | -342 | -235 | -481 | -1,719 | -2,538 |